Home
Conditions
Hepatitis C

Clinical trial condition

Hepatitis C

Explore clinical trials studying Hepatitis C. Study availability and eligibility vary by location and protocol.

449 public trials 3 recruiting studies

Refine in advanced search Browse all conditions

Hepatitis C trial results

Completed

Individualized Triple-therapy Using Boceprevir in HIV-positive Patients With Hepatitis C

NCT01925183

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +15 more
Locations: Division of Gastroenterology and Hepatology, Department of Internal Medicine III, Medical University of Vienna Vienna, State of Vienna, Austria

View Trial Details

Completed

Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir

NCT02113631

Conditions: Blood-Borne Infections, Chronic Disease, Cirrhosis, +16 more
Locations: Louis Stokes Cleveland VA medical center Cleveland, Ohio, United States

View Trial Details

Completed

Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs

NCT03063723

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C (Disorder), +15 more
Locations: Not specified

View Trial Details

Completed

Clinical Pharmacology Study of MP-424

NCT01766167

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Seoul, South Korea

View Trial Details

Completed

French Cohort of Therapeutic Failure and Resistances in Patients Treated With a Protease Inhibitor (Telaprevir or Boceprevir), Pegylated Interferon and Ribavirin

NCT01514890

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations: Hôpital Henri Mondor Créteil, France

View Trial Details

Completed

Orange Juice Consumption in Patients With Hepatitis C

NCT03026569

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Infection, +16 more
Locations: Sao Paulo State University "Julio de Mesquita Filho" Araraquara, São Paulo, Brazil

View Trial Details

Completed

The Individualized Management With Pegylated-interferon Alfa-2a (Pegasys) and Ribavirin (Copegus) Offering Viral Eradication: A Study of Pegylated-interferon Alfa-2a Plus Ribavirin in Participants With Chronic Hepatitis C (CHC) Non-genotype 2/3 (IMPROVE)

NCT00483938

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Milwaukee, Wisconsin, United States

Calgary, Alberta, Canada

Edmonton, Alberta, Canada

Edmonton, Alberta, Canada

View all 23 locations

View Trial Details

Completed

Ombitasvir/Paritaprevir/Ritonavir and Dasabuvir Co-Administered With Sofosbuvir With and Without Ribavirin in Treatment-Naive HCV Genotype 1-Infected Adults

NCT02399345

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C Virus (HCV Infection Genotype 1), +15 more
Locations: Not specified

View Trial Details

Completed

A Retrospective Study to Assess the Impact of the Use of Interferon in Patients With Chronic Hepatitis C (DECISION)

NCT01280656

Conditions: Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations: Rio Branco, Acre, Brazil

Manaus, Amazonas, Brazil

Vitória, Espírito Santo, Brazil

Salvador, Estado de Bahia, Brazil

View all 37 locations

View Trial Details

Completed

Efficacy and Safety Study of Simeprevir in Combination With Sofosbuvir in Subjects With Chronic Genotype 4 Hepatitis C Virus Infection

NCT02250807

Conditions: Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +16 more
Locations: Badalona, Spain

Barcelona, Spain

Madrid, Spain

Santander, Spain

View Trial Details

Hepatitis C

Hepatitis C trial results

Related conditions